The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development
The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development
复制标题
DOI：
10.3389/fonc.2016.00215
复制
发表时间：
2016-10-13
影响因子：
4.7
通讯作者：
van Vulpen, Marco
中科院分区：
文献类型：
--
作者：
Kerkmeijer, Linda G. W.;Fuller, Clifton D.;van Vulpen, Marco
已经形成了一个国际研究联盟，以促进循证引入MR引导放射治疗（MR-linac），并解决如何使用MR-linac实现优化的放射治疗方法，以改善患者的生存率，局部和区域肿瘤控制和生活质量。本文介绍了MR直线加速器联盟的临床部分的组织结构。此外，它阐明了为什么在这个大型项目上的合作是必要的，以及如何实施中央数据注册程序。
An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.